1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hrabal, R. Komives, E.A. Ni, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US Protein Sci. PRCIEI 0795 0961-8368 5 195 203 8745396 Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin. 1996 10.2210/pdb1fge/pdb pdb_00001fge 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 NON-NATIVE DISULFIDE BOND BETWEEN THE FOURTH CYSTEINE (CYS 407) AND THE SIXTH CYSTEINE (CYS 421) 2218.372 THROMBOMODULIN C-TERMINAL SUBDOMAIN, RESIDUES 407 - 426, OF 5TH EPIDERMAL GROWTH FACTOR (EGF) C409A 1 man polymer no no CEAPEGYILDDGFICTDIDE CEAPEGYILDDGFICTDIDE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1996-06-20 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1995-11-28 REL REL 14 BRUNGER refinement X-PLOR 3.1 CYS 407 n 1 CYS 407 A GLU 408 n 2 GLU 408 A ALA 409 n 3 ALA 409 A PRO 410 n 4 PRO 410 A GLU 411 n 5 GLU 411 A GLY 412 n 6 GLY 412 A TYR 413 n 7 TYR 413 A ILE 414 n 8 ILE 414 A LEU 415 n 9 LEU 415 A ASP 416 n 10 ASP 416 A ASP 417 n 11 ASP 417 A GLY 418 n 12 GLY 418 A PHE 419 n 13 PHE 419 A ILE 420 n 14 ILE 420 A CYS 421 n 15 CYS 421 A THR 422 n 16 THR 422 A ASP 423 n 17 ASP 423 A ILE 424 n 18 ILE 424 A ASP 425 n 19 ASP 425 A GLU 426 n 20 GLU 426 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ILE 414 -170.10 112.07 1 A PHE 419 77.11 147.15 1 A ILE 420 -138.85 -63.40 1 A CYS 421 177.68 98.90 1 A THR 422 69.84 122.76 1 A ASP 423 -148.12 -53.48 1 A ASP 425 -112.30 72.69 2 A ILE 414 -169.71 105.15 2 A PHE 419 75.14 148.83 2 A ILE 420 -143.86 -59.89 2 A CYS 421 178.13 96.12 2 A THR 422 70.21 122.66 2 A ASP 423 -145.75 -60.68 2 A ASP 425 -104.64 62.12 3 A GLU 408 66.60 148.27 3 A ILE 414 -171.10 104.83 3 A PHE 419 75.03 147.25 3 A ILE 420 -142.18 -63.82 3 A CYS 421 -179.49 105.94 3 A THR 422 67.16 116.53 3 A ASP 423 -149.76 -60.91 3 A ASP 425 -104.65 65.63 4 A GLU 408 66.41 150.58 4 A ILE 414 -171.68 105.23 4 A PHE 419 73.05 147.64 4 A ILE 420 -143.10 -63.51 4 A CYS 421 -178.42 101.19 4 A THR 422 70.02 118.61 4 A ASP 423 -148.28 -54.79 4 A ASP 425 -106.70 71.28 5 A ILE 414 -172.38 102.59 5 A PHE 419 73.72 147.62 5 A ILE 420 -143.77 -61.86 5 A CYS 421 179.50 110.88 5 A THR 422 64.49 103.62 5 A ASP 423 -142.25 -37.13 6 A GLU 408 66.27 150.65 6 A ILE 414 -170.60 103.26 6 A PHE 419 71.82 147.92 6 A ILE 420 -143.13 -62.59 6 A CYS 421 178.48 112.68 6 A THR 422 66.24 103.93 6 A ASP 423 -143.05 -39.20 7 A GLU 408 65.32 154.96 7 A ILE 414 -172.35 105.78 7 A PHE 419 70.88 148.11 7 A ILE 420 -143.78 -63.47 7 A CYS 421 -177.84 101.27 7 A THR 422 70.85 118.48 7 A ASP 423 -147.84 -54.12 7 A ASP 425 -106.83 71.16 8 A ILE 414 -165.88 112.62 8 A PHE 419 77.68 146.57 8 A ILE 420 -140.92 -57.40 8 A CYS 421 -171.14 -132.61 8 A ASP 425 -117.96 75.50 9 A GLU 408 65.93 153.63 9 A ILE 414 -161.90 111.78 9 A PHE 419 73.56 146.28 9 A ILE 420 -143.81 -59.30 9 A CYS 421 -166.98 -129.92 9 A ASP 423 -145.61 -55.02 9 A ASP 425 -115.23 71.70 10 A ILE 414 -160.65 111.06 10 A PHE 419 71.20 148.05 10 A ILE 420 -143.29 -56.97 10 A CYS 421 -173.72 -125.14 10 A ASP 423 -144.22 -54.67 10 A ASP 425 -114.60 73.49 11 A PRO 410 -74.87 -168.24 11 A ILE 414 -171.40 104.19 11 A PHE 419 75.01 148.35 11 A ILE 420 -143.77 -60.90 11 A CYS 421 178.90 97.37 11 A THR 422 70.29 122.46 11 A ASP 423 -148.68 -52.22 11 A ASP 425 -112.56 73.85 12 A GLU 408 66.15 151.18 12 A ILE 414 -160.01 111.18 12 A PHE 419 70.97 146.33 12 A ILE 420 -143.42 -59.29 12 A CYS 421 -168.18 -131.07 12 A ASP 423 -139.34 -60.54 12 A ASP 425 -106.16 58.59 13 A ILE 414 -170.21 102.38 13 A PHE 419 74.82 147.83 13 A ILE 420 -144.01 -60.53 13 A CYS 421 177.26 107.78 13 A THR 422 65.16 107.10 13 A ASP 423 -144.19 -39.49 13 A ASP 425 -100.66 64.37 14 A GLU 408 67.98 142.12 14 A ILE 414 -173.22 107.31 14 A PHE 419 72.67 148.84 14 A ILE 420 -142.85 -62.72 14 A CYS 421 -179.40 97.36 14 A THR 422 70.73 121.65 14 A ASP 423 -145.99 -55.89 14 A ASP 425 -104.03 69.13 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 EPIDERMAL GROWTH FACTOR (EGF) SUBDOMAIN OF HUMAN THROMBOMODULIN (NMR, 14 STRUCTURES) 1 Y N disulf 2.024 A CYS 407 A SG CYS 1 1_555 A CYS 421 A SG CYS 15 1_555 BLOOD COAGULATION INHIBITOR BLOOD COAGULATION INHIBITOR, THROMBOMODULIN, EGF TRBM_HUMAN UNP 1 1 P07204 MLGVLVLGALALAGLGFPAPAEPQPGGSQCVEHDCFALYPGPATFLNASQICDGLRGHLMTVRSSVAADVISLLLNGDGG VGRRRLWIGLQLPPGCGDPKRLGPLRGFQWVTGDNNTSYSRWARLDLNGAPLCGPLCVAVSAAEATVPSEPIWEEQQCEV KADGFLCEFHFPATCRPLAVEPGAAAAAVSITYGTPFAARGADFQALPVGSSAAVAPLGLQLMCTAPPGAVQGHWAREAP GAWDCSVENGGCEHACNAIPGAPRCQCPAGAALQADGRSCTASATQSCNDLCEHFCVPNPDQPGSYSCMCETGYRLAADQ HRCEDVDDCILEPSPCPQRCVNTQGGFECHCYPNYDLVDGECVEPVDPCFRANCEYQCQPLNQTSYLCVCAEGFAPIPHE PHRCQMFCNQTACPADCDPNTQASCECPEGYILDDGFICTDIDECENGGFCSGVCHNLPGTFECICGPDSALARHIGTDC DSGKVDGGDSGSGEPPPSPTPGSTLTPPAVGLVHSGLLIGISIASLCLVVALLALLCHLRKKQGAARAKMEYKCAAPSKE VVLQHVRTERTPQRL 425 444 1FGE 407 426 P07204 A 1 1 20 1 CYS conflict ALA 409 1FGE A P07204 UNP 427 3 1 P 1